Prospective Cohort Study of Children Diagnosed with Type 1 Diabetes in Türkiye Between 2018 to 2022

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06892821

Enrollment

2730

Registered

2025-03-25

Start date

2018-01-01

Completion date

2022-12-31

Last updated

2025-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus (T1DM)

Keywords

type 1 diabetes mellitus, children, adolescent

Brief summary

Achieving glycemic targets with improved T1DM management reduces diabetes complications and the risk of progression. Thus, it is essential to identify the challenges in T1DM management within the country and develop strategies for improvement. In Türkiye, there is limited multicenter data regarding the clinical characteristics of children and adolescents with T1DM during the diagnosis and treatment process. This multicenter prospective cohort study aimed to determine the diagnostic and follow-up characteristics of children and adolescents with T1DM, assess the status of diabetes management in the country.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

2 Months to 18 Years

Healthy volunteers

Inclusion criteria

* Type 1 diabetes mellitus can develop in individuals between the ages of 2 months and 18 years.

Exclusion criteria

* other types of diabetes mellitus

Design outcomes

Primary

Measure	Time frame
HbA1c	Through study completion, HbA1c will be measured during the 1st, 2nd, 3rd, 4th, and 5th years of treatment.
diabetes microvascular complications	through study completion, diabetes microvascular complications will be assessed during the 1st, 2nd, 3rd, 4th, and 5th years of treatment.

Countries

Turkey (Türkiye)

Outcome results